⌘K

Login Start Free

Home/Filings/4/0001209191-06-018462

4//SEC Filing

CARDIOGENESIS CORP /CA 4

Accession 0001209191-06-018462

CIK 0000863680operating

View on SEC.gov Company Profile

Filed

Mar 16, 7:00 PM ET

Accepted

Mar 17, 1:52 PM ET

Size

6.8 KB

Accession

0001209191-06-018462

Insider Transaction Report

Form 4

Period: 2006-03-17

CARDIOGENESIS CORP /CACGCP

QUINN MICHAEL J

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
2006-03-17$0.32/sh+100,000$32,000→ 402,650 total
Exercise/Conversion
Stock Option (Right to Buy)
2006-03-17−100,000→ 89,008 total
Exercise: $0.32From: 2003-01-07Exp: 2013-01-07→ Common Stock (100,000 underlying)

Documents

1 file

4
biv18747_biv1mjq.xmlPrimary
MAIN DOCUMENT DESCRIPTION

Issuer

CARDIOGENESIS CORP /CA

CIK 0000863680

Entity typeoperating

IncorporatedCA

Related Parties

1

filerCIK 0000863680

Filing Metadata

Form type: 4
Filed: Mar 16, 7:00 PM ET
Accepted: Mar 17, 1:52 PM ET
Size: 6.8 KB

View on SEC.gov